117 related articles for article (PubMed ID: 30130284)
1. Hormone therapy in postmenopausal women associated with risk of stroke and venous thromboembolism: a population-based cohort study in Taiwan.
Chang WC; Wang JH; Ding DC
Menopause; 2019 Feb; 26(2):197-202. PubMed ID: 30130284
[TBL] [Abstract][Full Text] [Related]
2. Hormone therapy and risk of venous thromboembolism among postmenopausal women in Taiwan - a 10-year nationwide population-based study.
Lee CH; Cheng CL; Kao Yang YH; Lin LJ
Circ J; 2015; 79(5):1107-14. PubMed ID: 25753572
[TBL] [Abstract][Full Text] [Related]
3. Concurrent use of Chinese herbal medicine among hormone users and its association with ischemic stroke risk: A population-based study.
Wen SH; Chang WC; Hong MK; Wu HC
J Ethnopharmacol; 2018 Apr; 216():274-282. PubMed ID: 29366767
[TBL] [Abstract][Full Text] [Related]
4. Hormone therapy is not associated with the risk of sudden sensorineural hearing loss in postmenopausal women: a 10-year nationwide population-based study.
Chen PJ; Chung CH; Chien WC; Chen HC
Menopause; 2019 Aug; 26(8):892-898. PubMed ID: 30969183
[TBL] [Abstract][Full Text] [Related]
5. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
[TBL] [Abstract][Full Text] [Related]
6. Concurrent use of statins and hormone therapy and risk of venous thromboembolism in postmenopausal women: a population-based case-control study.
Fournier JP; Duijnhoven RG; Renoux C; Dell'Aniello S; Klungel OH; Suissa S
Menopause; 2014 Sep; 21(9):1023-6. PubMed ID: 24937027
[TBL] [Abstract][Full Text] [Related]
7. Long term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A
Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
[TBL] [Abstract][Full Text] [Related]
8. Use of antipsychotics and risk of venous thromboembolism in postmenopausal women. A population-based nested case-control study.
Wang MT; Liou JT; Huang YW; Lin CW; Wu GJ; Chu CL; Yeh CB; Wang YH
Thromb Haemost; 2016 Jun; 115(6):1209-19. PubMed ID: 26941052
[TBL] [Abstract][Full Text] [Related]
9. Type 1 diabetes is associated with an increased risk of venous thromboembolism: A retrospective population-based cohort study.
Peng YH; Lin YS; Chen CH; Tsai KY; Hung YC; Chen HJ; Liao WC; Ho WC
PLoS One; 2020; 15(1):e0226997. PubMed ID: 31935226
[TBL] [Abstract][Full Text] [Related]
10. Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women's Health Initiative Hormone Therapy clinical trials.
Canonico M; Plu-Bureau G; O'Sullivan MJ; Stefanick ML; Cochrane B; Scarabin PY; Manson JE
Menopause; 2014 Mar; 21(3):214-20. PubMed ID: 23760439
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy for preventing cardiovascular disease in post-menopausal women.
Main C; Knight B; Moxham T; Gabriel Sanchez R; Sanchez Gomez LM; Roqué i Figuls M; Bonfill Cosp X
Cochrane Database Syst Rev; 2013 Apr; (4):CD002229. PubMed ID: 23633307
[TBL] [Abstract][Full Text] [Related]
12. Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke.
Li YR; Tsai SS; Chen DY; Chen ST; Sun JH; Chang HY; Liou MJ; Chen TH
Cardiovasc Diabetol; 2018 Jan; 17(1):2. PubMed ID: 29301579
[TBL] [Abstract][Full Text] [Related]
13. How do you decide on hormone replacement therapy in women with risk of venous thromboembolism?
Lekovic D; Miljic P; Dmitrovic A; Thachil J
Blood Rev; 2017 May; 31(3):151-157. PubMed ID: 27998619
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes.
Bassuk SS; Manson JE
Ann Epidemiol; 2015 Mar; 25(3):193-200. PubMed ID: 25534509
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of venous thromboembolism in patients with dermatomyositis/polymyositis: a nationwide cohort study.
Chung WS; Lin CL; Sung FC; Lu CC; Kao CH
Thromb Res; 2014 Sep; 134(3):622-6. PubMed ID: 25034321
[TBL] [Abstract][Full Text] [Related]
16. Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies.
Carrasquilla GD; Frumento P; Berglund A; Borgfeldt C; Bottai M; Chiavenna C; Eliasson M; Engström G; Hallmans G; Jansson JH; Magnusson PK; Nilsson PM; Pedersen NL; Wolk A; Leander K
PLoS Med; 2017 Nov; 14(11):e1002445. PubMed ID: 29149179
[TBL] [Abstract][Full Text] [Related]
17. Estrogen Therapy and Ischemic Stroke in Women with Diabetes Aged Over 55 Years: A Nation-Wide Prospective Population-Based Study in Taiwan.
Chen YH; Hsieh TF; Lee CC; Wu MJ; Fu YC
PLoS One; 2015; 10(12):e0144910. PubMed ID: 26658781
[TBL] [Abstract][Full Text] [Related]
18. Incidence and risk of venous thromboembolism in patients following appendectomy: a nationwide cohort study.
Chung WS; Chen Y; Chen W; Lin CL
J Thromb Thrombolysis; 2019 Oct; 48(3):483-490. PubMed ID: 31177485
[TBL] [Abstract][Full Text] [Related]
19. Progestogens and venous thromboembolism among postmenopausal women using hormone therapy.
Canonico M; Plu-Bureau G; Scarabin PY
Maturitas; 2011 Dec; 70(4):354-60. PubMed ID: 22024394
[TBL] [Abstract][Full Text] [Related]
20. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.
Olié V; Plu-Bureau G; Conard J; Horellou MH; Canonico M; Scarabin PY
Menopause; 2011 May; 18(5):488-93. PubMed ID: 21178641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
